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Background: The lung epithelium constitutes the first barrier against invading pathogens and also a major surface
potentially exposed to nanoparticles. In order to ensure and preserve lung epithelial barrier function, the alveolar
compartment possesses local defence mechanisms that are able to control bacterial infection. For instance, alveolar
macrophages are professional phagocytic cells that engulf bacteria and environmental contaminants (including
nanoparticles) and secrete pro-inflammatory cytokines to effectively eliminate the invading bacteria/contaminants.
The consequences of nanoparticle exposure in the context of lung infection have not been studied in detail.
Previous reports have shown that sequential lung exposure to nanoparticles and bacteria may impair bacterial
clearance resulting in increased lung bacterial loads, associated with a reduction in the phagocytic capacity of
alveolar macrophages.
Results: Here we have studied the consequences of SiO2 nanoparticle exposure on Pseudomonas aeruginosa
clearance, Pseudomonas aeruginosa-induced inflammation and lung injury in a mouse model of acute pneumonia.
We observed that pre-exposure to SiO2 nanoparticles increased mice susceptibility to lethal pneumonia but did
not modify lung clearance of a bioluminescent Pseudomonas aeruginosa strain. Furthermore, internalisation of SiO2
nanoparticles by primary alveolar macrophages did not reduce the capacity of the cells to clear Pseudomonas
aeruginosa. In our murine model, SiO2 nanoparticle pre-exposure preferentially enhanced Pseudomonas
aeruginosa-induced lung permeability (the latter assessed by the measurement of alveolar albumin and IgM
concentrations) rather than contributing to Pseudomonas aeruginosa-induced lung inflammation (as measured
by leukocyte recruitment and cytokine concentration in the alveolar compartment).
Conclusions: We show that pre-exposure to SiO2 nanoparticles increases mice susceptibility to lethal pneumonia but
independently of macrophage phagocytic function. The deleterious effects of SiO2 nanoparticle exposure during
Pseudomonas aeruginosa-induced pneumonia are related to alterations of the alveolar-capillary barrier rather than to
modulation of the inflammatory responses.
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The explosion in the use of manufactured nanoparticles
(NPs) will undoubtedly be associated worldwide with a
potentially increased exposure (accidental or intentional)
of the population to these agents. The lung epithelium
constitutes the largest surface of contact with the envi-
ronment, and as such, can be considered as the major
surface accidentally exposed to NPs. However, the lung
epithelium should also be regarded as a desired target
for the delivery of drugs or diagnostic agents based on
NPs (intentional exposure). Among NPs, SiO2 NPs are
produced in high quantities and have important applica-
tions not only in consumer products but also in the field
of nanomedicine [1].
Once inhaled, NPs will be deposited in different
regions of the lungs, including the alveoli [2]. After their
entry in the alveolar space, NPs encounter alveolar
macrophages (AMs) and epithelial cells. AMs are profes-
sional phagocytic cells that recognize invading microbes,
including bacteria, and release cytokines and inflamma-
tory mediators needed to mount host responses against
these pathogens [3]. Bacterial clearance by AMs is initi-
ated by recognition of the pathogen by phagocytic recep-
tors at the cell surface. Then, further internalization
occurs, ultimately resulting in the degradation of the
engulfed bacteria in the phagolysosome [4].
Particularly relevant to the lung, Pseudomonas aerugi-
nosa (P.a) can be found in ventilator-associated pneu-
monia in nosocomial infections [5]. Importantly, it also
colonizes the lungs of cystic fibrosis patients contribut-
ing significantly to morbidity and mortality in this
disease [6]. P.a respiratory infection is associated with
lung inflammation and increased permeability of the
alveolocapillary barrier [7]. Eradication of P.a from the
lungs of the patients is difficult due to multiple drug-
resistance of the bacterium. In that context, new promis-
ing therapies may be based on the use of silica-derived
NPs as efficient carriers for antibacterial agents [8,9].
However in order to develop a therapeutic use of NPs
against lung infections, it is important first to character-
ise the consequences of NP exposure on target cells, es-
pecially innate immune cells. Indeed inhaled NPs can
target immune cells, including AMs. Uptake of NPs by
AMs might follow endocytic as well as non-endocytic
pathways, including passive diffusion [10,11]. Once they
are engulfed, NPs can accumulate in lysosomes of
macrophages [12-14]. Considering that bacterial and NP
uptake converge within the endocytic pathway, it is ra-
tional to hypothesize that adverse effects of NP exposure
might include impairment of phagocyte function. Indeed
it has been shown that in vitro exposure of macrophages
to carboxyl polystyrene or aluminium derived NPs hin-
dered their phagocytic capacity [15,16]. Moreover, intra-
tracheal instillation of small-sized titanium dioxide torats modified the phagocytic capacity of isolated AMs in
a concentration dependent-manner [17]. In the context
of lung infection, recent studies indicate that sequential
lung exposure to carbon nanotubes or cupper NPs
followed by Listeria monocytogenes or Klebsiella pneu-
moniae challenge, respectively increase lung inflam-
mation and reduce bacterial clearance compared with
animals not exposed to NPs [18,19]. Although im-
paired bacterial clearance was associated with reduced
phagocytic activity of AMs after NP exposure [19],
neither of these studies could discriminate the effects
of NPs alone, from the effects of NPs plus bacteria,
since NPs alone administration was associated with
inflammation and lung injury. In consequence, effects
of NP pre-exposure on lung infection could be due to
NP-associated inflammation rather than to a direct
action on AM phagocytic activity.
Here we have evaluated the effects of SiO2 NP pre-
exposure followed by P.a infection, two environmental
insults not studied in combination before. We focussed
our study in determining the consequences of SiO2 NP
exposure on P.a clearance and P.a-induced inflamma-
tion and lung injury in a mouse model of acute pneumo-
nia. We selected short exposure times in order to reduce
lung inflammation potentially associated with NPs and
to optimize the uptake of SiO2 NPs by AM in vivo. We
report here that pre-exposure to SiO2 NPs increased
mice susceptibility to lethal pneumonia but interestingly
independently of an impairment of AM phagocytic
function. Instead, SiO2 NPs pre-exposure enhanced
P.a-induced alterations of the lung alveolar-capillary
barrier without affecting lung inflammation.Results
Characterisation of silica NPs
Fluorescent or unlabelled 15 nm SiO2 NPs were
synthetized and characterized by dynamic light scat-
tering (DLS) as previously described [20,21]. DLS ana-
lysis demonstrated that both types of NPs presented a
hydrodynamic diameter of 44.4 and 50.9 nm respect-
ively in water (Table 1) showing a low aggregation
rate in solution. Moreover, NP preparations were
relatively stable in physiological media because the
hydrodynamic diameter did not change when increas-
ing ionic strength of the media (compare hydro-
dynamic diameter of NP suspensions in water versus
PBS or RPMI culture media). In addition we measured
endotoxin content in NP preparations by the LAL
method [22] (Table 1). Following this procedure the
quantity of endotoxin detected in our NP preparations
was <0.25 EU/mg. These measurements were per-
formed at doses of NPs that did not interfere with the
LAL chromogenic test.
Table 1 Nanoparticle characterisation
Nanopaticle Physico-chemical properties Endotoxin
Water PBS RPM
Size (nm) Pdl Z-pot (mV) Size (nm) Pdl Z-pot (mV) Size (nm) Pdl Z-pot (mV)
SiO2 50.9 0.271 −11.2 53.6 0.217 −10.1 68.1 0.207 −13.2 <0.25 EU/mg
FITC-SiO2 44.4 0.262 −64.5 56.4 0.306. −10.5 54.4 0.305 −21.9 <0.25 EU/mg
Labelled or unlabelled 15 nm SiO2 NPs were characterised in different media. The hydrodynamic size of agglomerates and polydispersity index (PdI) of
suspensions were determined by DLS and their charge by measuring the zeta-potential (Z-pot). Endotoxin detection was performed by the Limulus amebocyte
Assay (LAL) method following manufacturer’s instructions. Detection limit of the assay was 0.1 EU/ml and concentration of NPs in the assay was 0.4 mg/ml.
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instillation and colocalize with alveolar epithelial cells at
longer exposure time
To study the consequences of NP exposure on P.a lung
infection, we set up a protocol where mice were first
treated with SiO2 NPs (5 mg/kg) and 5 h later infected
with the P.a strain PAK (Figure 1). For most of our
experiments, we selected 5 h time after NP treatment as
a time point for infection because at that time, we did
not observed obvious signs of inflammation (including
neutrophil accumulation) in the lungs of NP treated
mice compared to controls (Figure 2). In addition,
because neutrophil influx usually starts 6 hours post-
LPS instillation [23,24], this indirectly also confirms that
LPS is undetectable and if present, is biologically inactive
in our NP preparations. However, in one parallel experi-
ment, 24 h after NP instillation a slight inflammation
was detected in the lungs characterized by increased
levels of KC (CXCL-1, a neutrophil chemokine) and a
slight neutrophil accumulation (less than 10% of total
cells) (Figure 2). Higher doses of SiO2 NPs increased
pro-inflammatory cytokines 24 h after treatment (data
not shown). Because our goal was to study NP effects
independently of its pro-inflammatory activity, we there-
fore selected a dose of 5 mg/Kg for the SiO2 NP treat-
ments and chose 5 h post NP instillation as the timeFigure 1 Experimental design. C57Bl/6j mice were intranasally
instilled with silica nanoparticles (5 mg/Kg) or vehicle and 5 h post
NPs instillation infected with P.aeruginosa by intranasal instillation.
18 h after infection, inflammatory markers in the lungs were
analysed by measuring cytokines and neutrophil recruitment in the
broncho-alveolar lavages (BALs). Bacterial loads were studied by
bioluminescence after infection with a Pa-luciferase producing strain.
Distribution of fluorescently labelled FITC SiO2 NPs (Fate of NPs) was
followed by immunofluorescence analysis of cells present in BALs
and lung tissues.point when P.a was administered (see below). At that
time point and in accordance with the quasi-exclusive
presence of AM (over 90%) and the absence of neutro-
phils in BALs, FITC-SiO2 or unlabelled SiO2 NP treat-
ment did not increase the basal levels of TNFα, KC, or
IL-6 in BAL fluid (Figure 2). Interestingly, at 5 h post-
NP instillation, over 15% of the cells present in the BAL
(mostly AM) internalized FITC-SiO2 NPs (Figure 3B and
D, white arrows). In accordance with the cytospin
analysis (Figure 2) most of the cells that internalized
SiO2 NPs presented an alveolar macrophage phenotype
(CD11c+ F4/80+) (Figure 3C). Therefore, these data and
the absence of inflammation after NP treatment alone
allowed us to study the consequences of NP exposure
on target cells without the confounding indirect effects
of pro-inflammatory response associated with NPs treat-
ment. Indeed, 24 h after FITC-SiO2 instillation, cryo-
sections of lungs showed that FITC-SiO2 NPs were
associated with lung epithelium and colocalized with
alveolar type II epithelial cells (labelled with an anti-pro
surfactant protein-C (SPC) antibody) (Figure 3E). Asso-
ciation of FITC-SiO2 with alveolar epithelial cells (AEC)
could explain the increased levels of KC (a typically
epithelial cell secreted chemokine) found in BALs 24 h
post instillation (Figure 2).
Silica NPs enhance permeability of alveolar-capillary
barrier
Because SiO2 NPs associated with AEC (Figure 3), and
as AECs guarantee epithelial barrier integrity [25], we
wondered whether SiO2 NPs could alter the alveolar-
capillary barrier integrity. This was assessed by measuring
IgM (a pentameric serum protein with a Mr 900 kDa)
concentration in BAL fluids. Increased amounts of IgM in
BAL fluids are related with alterations in alveolar-capillary
barrier and increased lung permeability as previously
described [24,26,27]. As show Figure 4A, SiO2 NP instilla-
tion increased the concentration of IgM in BALs 24 h post
treatment. Interestingly, at this time point, levels of soluble
vascular cell adhesion molecule-1 (sVCAM-1) in BALs, a
parameter related to endothelium injury and activation,
was not modified (Figure 4B). These data indicate that
SiO2 NPs increase alveolar-capillary barrier with minor
alterations of the vascular endothelium.
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Figure 2 Effects of silica nanoparticles on lung inflammation after instillation. A) C57Bl/6j mice were intranasally instilled with
FITC-SiO2 or unlabelled SiO2 nanoparticles (5 mg/kg;100 μg/mice) or vehicle. 5 h or 24 h after, concentration of pro-inflammatory cytokines
were measured in BALs (2 ml) (left panels). B) Cells present in BALs were cytospined and stained with Diff-Quick to identify macrophages
and neutrophils. A representative image of BAL cells in a control mice (upper panel) or SiO2 NPs treated mice are shown (lower panels).
Neutrophils (red arrow) were found in some NP treated mice 24 h post-instillation and represented less than 10% of total cells in BALs.
Mean ± SEM is represented from 4 to 6 mice per group. *p < 0.05 vs. Vehicle, Mann–Whitney test.
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during P. a-induced pneumonia
Considering that SiO2 NPs interact with AM and AEC,
two cell types driving lung defence against P.a, we
studied the consequences of NP exposure in a mouse
model of P.a infection. First we studied the effect of
NP exposure on P.a-induced mortality in mice. Intra-
nasal administration of 2x107 CFU per mice killed
almost 40% of mice 72 h post infection (Figure 5). Cru-
cially, pre-exposure to SiO2 NPs 5 h before bacterial
challenge enhanced mouse mortality by 20%, indicat-
ing a deleterious effect of NP exposure in our mice
model of acute pneumonia.Pre-exposure to silica NPs does not interfere with
bacterial clearance nor bacterial translocation in vivo
Our laboratory and others have reported that increased
mortality during P. aeruginosa pneumonia could be
associated with increased bacterial burden [28-30]. We
therefore analysed whether SiO2 NP pre-exposure en-
hanced bacterial loads in the lungs of infected mice. To
that aim, we studied the elimination of P.a in the whole
animal using a bioluminescence approach. Mice were
therefore infected with 107 CFU of a bioluminescent P.a
strain (PAK-lux) as previously described [29] and 15 h
later, bioluminescence was measured. We observed that
NP treated mice did not present a higher bacterial load
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Figure 3 Silica nanoparticles are internalized by alveolar macrophages and colocalize with alveolar epithelial cells. C57Bl/6j mice were instilled
with FITC-SiO2 NPs (5 mg/kg;100 μg/mice). A) 5 h later, mice were sacrificed and cells present in BALs were analysed by flow cytometry after labelling with
specific antibodies directed against alveolar macrophages markers (CD11c, F4/80). Panel B) shows that 15 ± 2% (n = 4, mice) of the cells were FITC positive.
Among them, over 95% were CD11c + and 85% CD11c + F4/80+ (panel C). The FACs analysis from one representative BAL from a total of 4 is shown. In
D) BAL cells were cytospined and stained with anti-mouse CD45 antibody followed by Alexa 664 Fluor (A664) coupled secondary antibody (red) to confirm
internalisation of FITC-SiO2 NPs (white arrows). E) Cryo-sections of lung tissues recovered from mice 24 h after instillation of FITC- SiO2 NPs (green) were
stained with anti-proSPC antibody (a marker of alveolar type II epithelial cells) followed by A664 coupled secondary antibody (red). White arrows indicate
co-localisation of NPs and alveolar epithelial cells. White scale bar = 100 μm or 20 μm (upper and lower panel, respectively). Nuclei were stained with DAPI
(blue). Fluorescence of stained cells and tissues were analysed under structured illumination (ApoTome system). Superposed images from FITC, A664, DAPI
and differential interferential contrast (D, lower panel) filters are shown. The ‘A’ within the figures indicates the alveolar spaces.
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and B). Rather NP-treatment showed a tendency to
reduce bacterial loads in lungs. To study further whether
NP treatment could induce bacterial translocation, we
dissected spleen and lungs to analyse associated bio-
luminescence. As shown in (Figure 6C), we did not de-
tect bacterial growth in the spleen. Analysis of dissectedVehicle SiO2 FITC-SiO2 SiO2 FIT
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Figure 4 Effects of silica NPs in alveolar-capillary permeability. C57Bl/
FITC- SiO2 NPs or vehicle. 5 h or 24 h later, mice were sacrificed and IgM (A
sandwich ELISA. Mean ± SEM is represented from 5 mice per group *p < 0.0lungs also confirmed that NP exposure did not increase
bacterial loads in lungs (Figure 6C).
Pre-exposure to silica NPs does not interfere with AM-
mediated bacterial clearance or AM cytokine output
AMs play a key role in P.a elimination from infected lungs
[7] and previous data have shown that NP exposure mayC-SiO2
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Figure 5 Survival curves of mice infected with Pseudomonas
aeruginosa strain PAK. C57Bl/6j mice were instilled with 5 mg/kg
(100 μg/mice) of SiO2 NPs or vehicle. 5 h after, mice were infected
with P. aeruginosa (PAK strain) (2x107 CFU/mice) and survival was
followed over time. (*) p < 0.05 Log-Rank (Mantel-Cox) test (n = 10
mice per group).
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To definitely rule out a decrease in bacterial clearance fol-
lowing NP treatment, we assessed the effect of NPs on
AM killing of P.a and on AM cytokine output. Ex-vivo
experiments on AM were performed by adding FITC or
unlabelled SiO2 NPs at non-toxic doses (2.5 μg/cm
2) at t0.
5 h later, over 50% of alveolar macrophages (53 ± 10%,
n = 3) had internalized FITC-SiO2 NPs (Figure 7A). At
that time point, extracellular NPs were washed out and
macrophages challenged with P.a (MOI =multiplicity ofSiO2/PAK Vehicle/PAK
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Figure 6 Effects of silica nanoparticles in bacterial clearance. A) Mice
with PAK-lux (107 CFU/mice). 15 h after infection, bioluminescence was rec
(panel C). B) Quantification of bioluminescence in the lungs. S = splee
In panel A) the rib cage is delimited within the squares.infection, 0.1 and 0.5). 4 h post-infection we measured
CFU in supernatants and cellular lysates to evaluate bac-
terial clearance as previously described [32]. As shown in
Figure 7B no differences were observed in the total num-
ber of bacteria recovered from alveolar macrophages cell
cultures, whether NP had been used or not.
Furthermore SiO2 NPs did not modify the P.a-induced
secretion of KC, TNFα or IL1β by AM (Figure 7C).
Taken together these data indicate that internalisation of
SiO2 NPs by AMs did not modify their capacity to elim-
inate P.a and did not modulate either the inflammatory
response induced by this bacterium.
Pre-exposure to silica NPs enhances alveolar-capillary
barrier permeability following P.a infection
Because changes in lung bacterial loads and the activa-
tion of AM could not explain the detrimental effects of
NP exposure on P.a infection, we explored whether SiO2
NPs may act through different mechanisms. For this
purpose, we measured the recruitment of neutrophils
and the concentrations of pro-inflammatory cytokines in
BAL fluids of mice treated (or not) with NPs and
infected with P.a. Expectedly, infection of P.a (2.5×106
CFU/mice), resulted in a sharp increase in neutrophils
associated with increased levels of KC, IL-6, TNFα, IL-
1β and IL-12 in BAL fluids (Figure 8) compared to non-SiO2/PAK Vehicle/PAK
/PAK vehicle/PAK SiO2/PAK vehicle/PAK
S
L L
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Figure 7 Effects of silica nanoparticles on bacterial clearance and AM inflammatory responses induced by P.a. Mice primary AMs (105
cells/well) from BALs were treated ex-vivo with FITC-SiO2 (A) or unlabelled SiO2 NPs (B and C) for 5 h at 2.5 μg/cm2 (0.8 μg/well) in culture media
(RPMI) (200 μl). In selected experiments, FITC-SiO2 treated cells were fixed and cytoskeleton and nuclei stained with phalloidin–tetramethylrhodamine
(red) and DAPI (blue), respectively. Fluorescence images were collected from observation on Apotome microscope (A). After incubation with NPs,
supernatants were removed and cells (105 cells/well) challenged with PAK at MOI 0.1 (B left panel) or MOI 0.5 (B right panel and C).
After 4 h, supernatants were collected and cells were lysed in 0,1% triton X-100, conditions that allow bacterial growth. Bacterial CFU
were counted in cell lysates and supernatants (CFU super + cell lysate) as shown in B. Concentration of cytokines were measured in cells
supernatants (200 μl) from untreated cells (RPMI/RPMI), cells treated with SiO2 NPs (SiO2/RPMI), cells challenged with bacteria (RPMI/PAK)
and cells exposed to SiO2 NPs and then challenged with bacteria (SiO2/PAK). Means ± SEM of triplicates from three independent pools of
alveolar macrophages are represented. Experiments were repeated twice. (n.d.) = not detectable.
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that pre-exposure to SiO2 NPs did not significantly
modify the number of recruited neutrophils post P.a in-
fection and neither the concentration of KC, TNFα, IL-
6, IL1β or IL-12 in BAL fluids. Finally and in agreement
with the capacity of NPs to alter alveolar-capillary bar-
rier (Figure 4), we wondered whether SiO2 NPs could
enhance the damage to the alveolar-capillary barrier
during infection, potentially explaining the observed
compromised mice survival (Figure 5). This was assessed
by measuring IgM and albumin (another serum protein
with a Mr of 67 kDa) concentration in BAL fluids.
Remarkably, we observed that IgM and albumin con-
centrations were increased in the BALs of infected
mice pre-exposed to SiO2 NP (Figure 8B), potentially
explaining the increased susceptibility associated with
NP treatment (Figure 5).
Discussion
Toxicity associated with NP exposure has been widely
documented. For instance, it has been described that
in vitro exposure of macrophages and epithelial cells to
NPs resulted in the induction of inflammatory responses
including release of pro-inflammatory cytokines and in-
duction of oxidative stress [33-35]. However these effectsmay depend on the composition of NPs, their physico-
chemical properties, presence of impurities as well as on
the duration of the exposure [35,36]. Our silica NP prep-
arations showed a relatively low pro-inflammatory activ-
ity in vitro and in vivo. Indeed, 5 h after intranasal
instillation of 5 mg/kg of SiO2 NP in mice, we did not
observe major signs of inflammation in the lungs even
when 15% of the cells in BALs (mostly macrophages)
had internalized those NPs. This is in stark contrast with
classical pro-inflammatory molecules like bacterial lipo-
polysaccharide (LPS). Inhalation of LPS in mice results
in acute lung inflammation characterized by elevated
levels of pro-inflammatory cytokines in BAL fluid as
soon as 3 h after administration [23]. When mice BAL
fluid were analysed 24 h after NP treatment, a very mod-
est inflammation was induced characterized by a low
percentage of neutrophils among BAL cells (less than
10%) and a slight increase in pro-inflammatory cytokines
(Figure 2). Furthermore, incubation ex-vivo of freshly
isolated AMs with silica NPs did not induce the release
of inflammasome-dependent (IL-1β) or -independent
cytokines (TNFα, KC, IL-6, CCL5, IL-12, IL-10, INFγ)
after 5 h of incubation (data not shown). In contrast to
many previous studies our NPs are well characterized,
they are not much aggregated and bacterial LPS was
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Figure 8 Effects of silica nanoparticles on inflammatory markers and alveolar-capillar permeability alterations induced by P.a infection.
Mice were treated with SiO2 NPs (5 mg/kg;100 μg/mice) (open bar) or vehicle (close bar) and 5 h later infected with PAK (2.5x106 CFU/mice).
18 h after infection, number of neutrophils and concentration of cytokines (A), IgM and albumin (B) were measured in BALs (2 ml). Basal levels of
KC, IL-6 TNFα in non-infected mice were 31 ± 7, 18 ± 4 and 26 ± 7 pg/ml (n = 4), respectively (see Figure 2). Basal levels of IL-12 and IL-1β were
50 ± 10 pg/ml and not detectable, respectively. Basal levels of IgM in BALs from non-infected mice were 17 ± 4 ng/ml (n = 5) (Figure 4).
The dotted line in B) represents basal levels of albumin in non-infected mice. Mean ± SEM is represented from 7 to 8 mice per group,
*p < 0.05 Mann–Whitney test.
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matory effect observed.
Several studies have described the consequences of NP
exposure on immune cells in terms of cellular activation
[36,37]. However fewer have focused on the effects of
NPs on subsequent anti-microbial host defence mecha-
nisms. We show here that acute exposure to SiO2 NPs
increased susceptibility to lethal lung pneumonia in-
duced by P.a. Furthermore, effects of NP exposure on
bacterial clearance were minimal in contrast to previ-
ous reports which show that sequential lung exposure
to NPs and bacteria impairs lung bacterial clearance
[18,19]. For instance, Kim and co-workers showed that
instillation of Cu NPs (from 0.12 to 4 mg/kg) 24 h be-
fore infection, increased the number of K.pneumoniae
found in BALs of infected mice [18]. In another inde-
pendent study, Shvedova and co-workers found that
carbon nanotube pre-exposure (2 mg/kg, 3 days beforeinfection) significantly decreased the pulmonary bac-
terial clearance of Listeria monocytogenes at days 3
and 7 post-infection despite robust inflammatory re-
sponses [19]. In contrast to our study, Cu NPs and
carbon nanotubes induced significant inflammation
‘per se’, which may have impair bacterial clearance by
mechanisms independent of AM phagocytic activity.
In addition Shvedova and co-workers have shown that
pre-exposure of AMs to carbon nanotubes reduces
their phagocytic/killing capacity toward L.monocyto-
genes [19]. By contrast, we show here that pre-exposure
of AM to SiO2 NPs did not modify P.a killing nor
P.a-mediated cytokine release by AM. Discrepancies
between our data and others could be due to the com-
position of NPs, size, shape, concentration, exposure
times or the cell type used [15,17,19,31]. In line with
our data, Witasp and co-workers showed that internalisa-
tion of mesoporous silica particles (>100 nm of diameter)
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macrophages to engulf apoptotic cells [38].
P.a respiratory infection is associated with lung in-
flammation and increased permeability of alveolocapil-
lary barrier [39,40]. Once in the host, the bacterium
activates alveolar resident cells (AM and AEC) to pro-
duce chemokines and cytokines [41] that activate im-
mune cells and attract inflammatory cells, including
neutrophils, to the alveolar space. Uncontrolled lung in-
flammation can result in increased tissue damage and
rupture of the epithelial barrier integrity with fatal con-
sequences for the host (compromised gas-exchange). To
measure the impact of SiO2 NP exposure on inflamma-
tion and lung permeability we measured the BAL con-
tent in neutrophils and pro-inflammatory cytokines as
well as albumin and IgM concentration, the two latter
reflecting increased lung permeability. Whereas concen-
tration of pro-inflammatory cytokines or neutrophil in-
flux in response to P.a infection were not different
between SiO2 NP exposed or unexposed mice, concen-
tration of albumin and IgM was higher in BAL fluids
from the former group. Interestingly, and echoing our
findings that NPs do no alter necessarily inflammatory
parameters, Swedin and co-workers found recently that
pre-exposure to carbon nanotubes did not alter lung in-
flammatory markers associated with a protozoan parasite
infection (Toxoplasma gondii) [42].
Although the molecular underlying mechanisms are
still unclear, we believe that increased local lung perme-
ability and oedema explain the major susceptibility to le-
thal P.a infection associated with SiO2 NP pre-exposure.
Several data support this hypothesis : firstly we observed
that SiO2 NPs target alveolar epithelium 24 h post instil-
lation (Figure 3E) and that NP instillation alone dis-
rupted the alveolar capillary barrier (as assessed by IgM
leakage, Figure 4). Further we estimated that less than
1% of instilled NPs translocate from lung into circulation
(not shown). Secondly, no systemic effect of NP treat-
ment was apparent, as demonstrated by the absence of
P.a translocation into the blood stream and the spleen
(Figure 6) and the absence of serum markers of systemic
tissue injury (Alanine Aminotransferase and Creatine
Kinase activities), 24 or 48 h post-infection (Additional
file 1: Figure S1).
Potentially explaining some of our results, oxidative
stress has been shown to be a key component mediating
P.a induced host-responses and lung injury [39,40].
Indeed, recent data indicate that regulation of inflam-
mation and lung permeability could be controlled by
different molecular mechanisms. Fu and co-workers
have shown that down-regulation of NADPH-oxidase
4 (NOX4) attenuated P.a–mediated lung permeability,
without affecting inflammatory responses of infected
mice. Conversely, knockdown of NOX2 reduced P.a–induced cytokine output without altering lung perme-
ability [39]. These data support the concept that lung
permeability and inflammation could be regulated by
independent mechanisms and therefore that SiO2 NPs
could preferentially affect permeability rather than
inflammation during P.a infection. In line with this, it
has been recently shown that TiO2 and SiO2 NPs
increased endothelial cell leakiness through physical
interactions with the endothelial junction protein VE-
cadherin and independently of the activation of pro-
inflammatory pathways [43]. These results are in line
with our data and point towards a new mechanism of
NP toxicity based on an increase of the permeability
of epithelial/endothelial barriers and the induction of
oedema.
Conclusions
We show here that pre-exposure to SiO2 NPs increases
susceptibility of mice to a lethal dose of P.a- in an acute
model of pneumonia, independently of AM phagocytic
function. SiO2 NP pre-exposure enhanced P.a-induced al-
veolar permeability and oedema, rather than P.a-induced
inflammation. An increase in alveolar-capillary permeabil-
ity is strongly correlated to lung injury and to an impaired
gas-exchange, which could explain the increased mortality
observed.
Methods
Synthesis and characterisation of NPs
15 nm FITC or unlabelled SiO2 NPs were synthesized as
described previously [20,21] following a slightly modified
method described by Van Blaaderen. Briefly, fluorescein
isothiocyanate (FITC) was covalently linked to 3-
aminopropyl-trimethoxysilane (APS) by reaction of
the amino group with the isothiocyanate group. 5 mg
of FITC was dissolved in 5 ml of 42.7 mM of APS in
ethanol. The fluorescein silane was added to 250 ml of
ethanol, 5 ml of TEOS (tetraethyl orthosilicate), 7.6 ml
of ammonium hydroxide (28%) and 10.9 ml of water.
The reaction was performed for 12 h at 50°C in the
dark under magnetic stirring. Estimation of silica con-
centration in the dispersion was carried out by induct-
ively coupled plasma optical emission spectrometry
(ICP-OES) and gravimetric method. DLS values as
well as the values of zeta potential of SiO2 NPs in dif-
ferent media were measured by Zetasizer (nanoZS,
Malvern Instruments, USA). Endotoxin content was
measured by the QCL-1000 Endpoint Chromogenic LAL
Assay following manufactured instructions (Lonza) at
doses of SiO2 NPs that did not interfere with the assay.
Interference of NPs with the assay was measured by in-
cluding a fixed quantity of NPs (20 μg) in the tubes con-
taining different concentrations of LPS standard. Optical
density at 405 nm of the tubes containing NPs was
Delaval et al. Particle and Fibre Toxicology  (2015) 12:1 Page 10 of 13compared with that of tubes without NPs for the same
LPS dose. Considering a detection limit for LAL assay of
0.1 EU/ml, we assumed the LPS contamination level in
our NPs preparations to be less than 0.25 EU/mg.
Animals
7-weeks-old male mice (strain C57BL/6 J) were obtained
from Janvier Labs (France). Animals were fed and
housed under standard conditions with air filtration and
cared for in accordance with Pasteur Institute guide-
lines and in compliance with European Animal Welfare
regulations.
Bacterial strains
The wild-type strain PAK, a commonly studied P.
aeruginosa strain, was obtained from S. Lory (Harvard
Medical School, Boston, MA), as originally isolated by
D. Bradley (Memorial University of Newfoundland, St.
John’s, Canada). Luminescent strain of PAK was con-
structed by inserting luxAB into the neutral att site of
the chromosome of strain PAK using a mini-Tn7-lux
plasmid provided by Microbiotix, in which luxAB is
driven by the lac promoter [44]. Bacteria were grown
overnight in Lysogeny Broth (LB) medium at 37°C and
then transferred to fresh medium and grown by shaking at
100 rpm for 4–5 h to mid-log phase. The culture was cen-
trifuged at 3.000 × g and the pellet was washed and resus-
pended in PBS. The OD600nm was adjusted to give the
desired inoculum. Inoculum was verified by serial dilu-
tions plated on LB agar to determine the number of
colony-forming unit (CFU). Bacterial growth of PAK and
PAK-lux strain was shown to be identical [29].
Co-exposure of mice to NPs SiO2 and P.a
Mice were anesthetized by intraperitoneal injection of a
mixture of ketamine-xylazine, and treated with SiO2 NPs
(5 mg/kg) (100 μg/mice) diluted in PBS or vehicle
(a mixture of PBS and H2O) via the intranasal route
(50 μL), as described elsewhere [32]. 5 h later, animals
were anesthetized and 50 μL of a bacterial suspension
containing 0.5 to 2.0 x 107 colony-forming units (CFU)
was administered by the intranasal route. In some mice,
survival was observed for 1 week after infection, and in
others broncho-alveolar lavage (BAL) was performed
(2 ml) after pentobarbital euthanasia 18 h after infection.
Cell counts were measured in the BAL fluids and cell
differential counts (presence of macrophages and neu-
trophils mainly) were determined after cytospin centrifu-
gation and staining with Diff-Quik products. Number of
cells per BAL per mouse are represented.
Concentration of cytokines, albumin and IgM
Murine cytokine (TNFα, IL-6, KC, IL-12, IL1β) and
sVCAM-1 concentrations in BAL fluid were determinedusing DuoSet sandwich enzyme-linked immunosorbent
assay kits (R&D Systems). Cytokines are expressed in
pg/ml in BALs (2 ml) present in each mouse for in vivo
experiments and in pg/ml per well (105 cells/well) in
in vitro experiments.
Mouse albumin was detected by ELISA sandwich.
Briefly: Maxisorb Nunc 96-well plates were coated with
capture antibody (goat anti-mouse albumin, 1/500 dilu-
tion, Bethyl Laboratories) overnight at 4°C in carbonate/
bicarbonate buffer (Sigma). After blocking (5% skim
milk-PBS, 1 h 37°C), serial dilutions of BAL fluid or
mouse albumin standard (Sigma) in 1% skim milk-PBS
were added to the plate and plates were incubated at
37°C for 1 h. After washing, secondary antibody (goat
anti-mouse albumin coupled to HRP, Bethyl Laborator-
ies) was added at 1/20000 dilution in 1% skim milk-PBS
and the plate was incubate at 37°C for 1 h. Excess of
antibody was washed out and TMB substrate (Sigma)
was added to develop the enzymatic reaction. After
addition of a stop solution (2 N H2SO4), the absorbance
associated with each well was measured at 450 nm in a
microplate reader.
Concentration of IgM was measured by ELISA sand-
wich following the same protocol as described above.
Coating was performed with a goat anti-mouse Ig anti-
body (1/500, Southern Biotech) and the secondary anti-
body was a goat anti-mouse IgM alkaline phosphatase
conjugated (1/4000, Southern Biotech). The enzymatic
reaction was developed after addition of alkaline phos-
phatase substrate (pNPP, Sigma) and measure of absorb-
ance at 405 nm in a microplate reader. Purified mouse
IgM (Sigma) was used as standard.
Bioluminescence measurements
Photon emission of the luminescent bacteria in the lungs
of infected mice was measured using the IVIS 100 sys-
tem (Xenogen Corp., Alameda, CA) as previously de-
scribed [29]. To achieve detection in C57BL/6 J mice,
chest hair was removed with a depilatory agent. 15 h
after infection, the mice were anesthetized under 2.5 %
isoflurane inhalation and photon emission is acquired by
a charge couple device (CCD) camera. A digital false-
color photon emission image was generated. The ana-
lysis was then performed with the Living Image software
(Xenogen Corp., Alameda, CA), by defining a constant
region of interested ( ROI) corresponding to the surface
of the chest encompassing the whole lung region. The
results are expressed as number of photons/sec/ROI.
Co-exposure of alveolar macrophages to SiO2 NPs and P.a
Mouse primary AM were isolated after lung bronchoal-
veolar lavage with PBS [23]. AM (105cells per 96-well
plate) were plated in complete RPMI medium (supple-
mented with 2 mM l-glutamine, 1% antibiotic, and 5%
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removed and cells were incubated overnight with fresh
medium. The next day, cells were incubated with SiO2
NPs (2.5 μg/cm2; 0.8 μg/well) in incomplete RPMI
medium (without serum or antibiotic) (200 μl) for 5 h.
Then a total of 105 cells were infected with bacteria
(MOI 0.1 or 0.5). In some wells the same quantity of
bacteria were inoculated in the absence of cells to obtain
the expected bacterial growth (100%). After 4 h, super-
natants (200 μl) were collected and cells were lysed with
0.1% Triton X-100 (a concentration that did not affect
PAK viability) in H2O in sequential washes to harvest
total bacteria. To quantify total viable bacteria, pooled
cell supernatants and lysates were diluted and plated on
LB agar to determine CFU scores as described previously
[32]. Potential cell toxicity after treatment was measured
by the CytoTox Non-Radioactive Cytotoxicity Assay
(Promega) that measures the percentage of cellular
lactate dehydrogenase released.
Fluorescence microscopy
Primary AM treated or not with FITC-SiO2 NPs grown
onto coverslips or cytospined cells from BAL were fixed
with formalin (10 min room temperature). After block-
ing (1% BSA-PBS), cells were incubated with rat IgG
anti-mouse CD45 antibody (BD Biosciences) followed by
Alexa-664-Fluor coupled secondary antibody (Invitrogen)
(membrane staining). Phalloidin–tetramethyl-rhodamine
(Sigma) was used for labelling cytoplasm. Nuclei were
stained with DAPI (Invitrogen). The preparations were
mounted with Vectashield (Dako) mounting media and
were analysed under structured illumination (ApoTome
system, Zeiss) using the corresponding filter for each
fluorochrome. Images were recovered and analysed by the
AxioVision programme and control cells (not treated with
FITC-SiO2 NPs) were included to measure fluorescence
background. Percentages of positive cells for each
preparation were obtained after counting of at least
100 cells in several fields. At least two independent ex-
periments were performed. Representative images are
shown in Figures 3 and 7.
Flow cytometry
BAL fluids from FITC-SiO2 NPs treated mice (5 mg/kg)
were recovered 5 h post NP instillation and cells were
centrifuged at 4°C (2000 rpm, 10 min). Cells were
washed in 1% BSA-PBS buffer and incubated with
monoclonal anti-mouse CD16/32 antibody (BD Biosci-
ences) for 15 min on ice to block Fc receptors. Cells were
then stained with a rat anti-mouse F4/80 antibody coupled
to eFluor450 (clone: BM8, eBioscience) and a hamster
anti-mouse CD11c antibody coupled to APC (clone: HL3,
BD Biosciences) (30 min, at 4°C in 1% BSA-PBS). After
washing, fluorescence associated with cells was acquiredin a CyAn ADP cytometer (Beckman Coulter). Analysis of
data was performed using FlowJo program. FITC positive
cells were only found in the macrophage gate (named R1
in FSC/SSC dot plot). To detect FITC positive cells from
negative cells, BAL fluids from non-treated mice were
obtained and treated in parallel to determine the auto-
fluorescence signal (characteristic of AM) from R1
population.ALT and CK enzymatic activity in mouse serum
Alanine Aminotransferase (ALT) activity was measured
from mouse serum using ALT- activity assay kit (Sigma)
following manufacturer’s instructions. The ALT activity
is determined by a coupled enzyme assay, which results
in a fluorogenic product (λex = 535 nm; λem =587 nm),
proportional to the pyruvate generated. ALT activity is
reported as nmol/min/mL =mU/mL where one unit (U)
is defined as the amount of enzyme that generates 1
μmole of pyruvate per minute at 37°C. Creatine Kinase
(CK) activity was measured from mouse serum using
CK-activity assay kit (Ray Biotech) following manufac-
turer’s instructions. The CK activity is determined by a
coupled enzyme assay, which results in a colored prod-
uct with strong optical density at 450 nm. CK activity is
reported as nmol/min/mL =mU/mL where one unit (U)
of CK is the amount of enzyme that will generate
1.0 μmol of NADH per minute at pH 9.0 at 37°C.Statistical analysis
Cytokine levels, polymorphonuclear neutrophil counts,
and pathogen counts were expressed as means ± stand-
ard errors of the mean (SEM). Differences between SiO2
NPs treated and non-treated groups were assessed for
statistical significance, using Mann–Whitney test (Prism
version 6, GraphPad). Differences were considered sta-
tistically significant at p < 0.05. Survival curves were
compared with Log-Rank (Mantel-Cox) test (Prism
version 6, GraphPad).Additional file
Additional file 1: Figure S1. Systemic toxicity of silica nanoparticles
during P.a infection. Mice were treated with SiO2 NPs (5mg/kg; 100μg/mice)
or vehicle and 5h later infected with PAK (2.5x106 CFU/mice) (‘SiO2/PAK’ and
‘PAK’ groups, respectively). A group of mice were only treated with SiO2
NPs (5mg/kg; 100μg/mice) (‘SiO2’) and another group only with vehicle
(‘vehicle’). 24h or 48h after NP instillation, Alanine Aminotransferase (ALT)
and Creatine Kinase (CK) activities were measured in the serum. Mean ±
SEM is represented from 5 mice per group.Abbreviations
AEC: Alveolar epithelial cells; AM: Alveolar macrophages; ALT: Alanine
Aminotransferase; BAL: Broncho-alveolar lavage; CK: Creatine Kinase;
MOI: Multiplicity of infection; NPs: Nanoparticles; P.a: Pseudomonas
aeruginosa; SP-C: Surfactant protein C.
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